Internap Corp (INAP) is Trading Lower on Unusual Volume for February 19

Equities Staff |

Internap Corp (INAP) experienced unusually high volume on Feb. 19, as the stock lost 30% to a closing price of $1.93. The stock saw 1.41 million shares trade hands over the course of the day on 5,984 trades. Given that the stock’s average daily volume over the last month has been 362,628 shares a day, this represents a pretty substantial spike over the norm.

Internap Corp has a P/B ratio of 0.87. The stock has traded between $10.75 and $2.71 over the last 52-weeks, its 50-day SMA is now $4.90, and its 200-day SMA $7.50.

Internap Corp is engaged in providing information technology infrastructure services. The Company provides services at data centers across North America, Europe and the Asia-Pacific region and through Internet Protocol service points.

Headquartered in Atlanta, GA, Internap Corp has 700 employees and is currently under the leadership of CEO Michael A. Ruffolo.

For a complete fundamental analysis analysis of Internap Corp, check out’s Stock Valuation Analysis report for INAP. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets


Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.


Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.